Previous studies have shown that Aβ derived from the brains of AD patients can inhibit long-term potentiation, cause synaptic loss, induce neuronal excitotoxicity, and promote hyperphosphorylation of tau proteins [88,153,160]. Here, MAPT is linked to Alzheimer disease.